Western Digital (NASDAQ:WDC – Get Free Report) had its price target hoisted by research analysts at Bank of America from $720.00 to $800.00 in a report issued on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the data storage provider’s stock. Bank of America’s price objective would indicate a potential upside of […]

LGN (NASDAQ:LGN – Get Free Report) had its price objective dropped by stock analysts at Barclays from $80.00 to $60.00 in a report issued on Monday, Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Barclays‘s price objective suggests a potential upside of 35.10% from the company’s current price. LGN has […]

Nextpower (NASDAQ:NXT – Free Report) had its price objective cut by Susquehanna from $157.00 to $150.00 in a research report released on Wednesday morning, Marketbeat Ratings reports. They currently have a positive rating on the stock. Several other research firms have also recently issued reports on NXT. Zacks Research cut shares of Nextpower from a […]

Ballard Power Systems (NASDAQ:BLDP – Free Report) (TSE:BLD) had its price objective trimmed by Susquehanna from $3.00 to $2.00 in a research report report published on Wednesday, MarketBeat.com reports. They currently have a neutral rating on the technology company’s stock. Several other equities analysts also recently commented on the company. UBS Group cut their target […]

Legend Biotech (NASDAQ:LEGN – Free Report) had its target price lowered by Barclays from $74.00 to $68.00 in a research note released on Tuesday morning,Benzinga reports. The firm currently has an overweight rating on the stock. LEGN has been the subject of a number of other reports. UBS Group restated a “buy” rating and issued […]

Plug Power (NASDAQ:PLUG – Get Free Report) had its target price reduced by equities researchers at Susquehanna from $2.50 to $1.75 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a “neutral” rating on the electronics maker’s stock. Susquehanna’s price target indicates a potential upside of 12.18% from the […]

Merlin, Inc. Common Stock (NASDAQ:MRLN – Free Report) had its price objective decreased by TD Cowen to $4.00 in a research report sent to investors on Friday morning,Benzinga reports. TD Cowen currently has a buy rating on the stock. Other analysts also recently issued research reports about the stock. Canaccord Genuity Group assumed coverage on […]

Mobileye Global (NASDAQ:MBLY – Free Report) had its price objective cut by UBS Group from $9.00 to $7.50 in a report published on Wednesday morning,Benzinga reports. They currently have a neutral rating on the stock. A number of other research firms have also recently issued reports on MBLY. Weiss Ratings reiterated a “sell (d-)” rating […]

CarGurus (NASDAQ:CARG – Free Report) had its price target decreased by UBS Group from $40.00 to $35.00 in a report released on Wednesday,Benzinga reports. UBS Group currently has a neutral rating on the stock. A number of other research firms also recently commented on CARG. B. Riley Financial reaffirmed a “buy” rating on shares of […]

Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) had its target price reduced by Truist Financial from $39.00 to $37.00 in a research note issued to investors on Wednesday morning, MarketBeat reports. Truist Financial currently has a buy rating on the biopharmaceutical company’s stock. AGIO has been the subject of a number of other reports. HC Wainwright […]

Neostellar Capital (NASDAQ:NSLR – Free Report) had its price objective lowered by BTIG Research from $15.00 to $14.00 in a report published on Wednesday, Marketbeat Ratings reports. The firm currently has a buy rating on the stock. Other analysts have also issued research reports about the stock. Barrington Research set a $16.00 price target on […]

Skyworks Solutions (NASDAQ:SWKS – Get Free Report) had its price objective hoisted by equities research analysts at Mizuho from $52.00 to $61.00 in a note issued to investors on Friday, Benzinga reports. The firm currently has an “underperform” rating on the semiconductor manufacturer’s stock. Mizuho’s target price would suggest a potential downside of 20.83% from […]

Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report) had its price objective lifted by investment analysts at BTIG Research from $810.00 to $826.00 in a report released on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. BTIG Research’s price objective suggests a potential upside of 197.10% from the company’s current […]